The Effect of Growth Hormone Secretagogues and Neuropeptide Y on Hypothalamic Hormone Release from Acute Rat Hypothalamic Explants
- 1 July 1999
- journal article
- research article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 11 (7), 521-528
- https://doi.org/10.1046/j.1365-2826.1999.00353.x
Abstract
Growth hormone (GH) secretagogues (GH-releasing peptides and their non-peptide analogues) stimulate growth hormone release via specific G-protein coupled receptors both directly from the pituitary gland and through stimulation of the hypothalamus. The exact mechanism of action in the hypothalamus is not known. The presence of endogenous GH releasing hormone (GHRH) seems to be necessary for the in-vivo actions of growth hormone secretagogues (GHSs), but data suggest that further factors must be involved as well. The effect of GHSs is not entirely specific for the GH axis; they release prolactin and stimulate the hypothalamo-pituitary-adrenal axis causing elevations in circulating ACTH and cortisol levels in both animal and human studies. Recently, it has also been suggested that GHSs stimulate hypothalamic neuropeptide Y (NPY) neurones. In the present study, we have therefore investigated the direct effect of several GHSs (GHRP-6, hexarelin and the non-peptide analogues L-692, 429 and L-692, 585) on GHRH, somatostatin (SS), corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP) release in vitro in an acute rat hypothalamic incubation system. We also assessed the effect of NPY on GHRH, SS and AVP release. Freshly removed hypothalami were incubated in control media for 20 min and then in 1–4 consecutive 20-min periods in each of the test substances at different concentrations. There was no significant change in either the basal or potassium-stimulated release of GHRH or SS at low concentrations of any of the secretagogues; however, at millimolar doses a paradoxical inhibition of GHRH was observed with GHRP-6, hexarelin and L-692 585 (data are expressed as the ratio of treated to preceding basal release; at 20 min control group: 0.97±0.02, GHRP-6: 0.55±0.04, P: 0.80±0.03, hexarelin: 1.23±0.07, P−4 M concentration of GHRP-6: 6.31±1, P1 receptor antagonist BIBP 3226 did not inhibit the effects of NPY on SS, GHRH or AVP release. We therefore conclude that, in this in-vitro rat hypothalamic incubation model, growth hormone secretagogues stimulate the release of AVP but have no effect on either GHRH, SS or CRH at low doses; at high doses paradoxically they inhibit the hypothalamic GH axis similar to in-vivo data in the rat. We speculate that these effects might be mediated by NPY.Keywords
This publication has 57 references indexed in Scilit:
- The Generation of Nitric Oxide and Carbon Monoxide Produces Opposite Effects on the Release of Immunoreactive Interleukin-1 from the Rat Hypothalamus in Vitro: Evidence for the Involvement of Different Signaling PathwaysEndocrinology, 1998
- Effect of Intravenous or Intracerebroventricular Injections of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on GH Release in Conscious, Freely Moving Male RatsNeuroendocrinology, 1996
- The effect of an opiate antagonist on the hormonal changes induced by hexarelinClinical Endocrinology, 1995
- Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP- 6 main action is exerted at the hypothalamic levelJournal of Clinical Endocrinology & Metabolism, 1995
- Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in manJournal of Clinical Endocrinology & Metabolism, 1994
- A Novel Non-Peptidyl Growth Hormone SecretagogueHormone Research, 1993
- Stimulation of Alpha-Adrenoceptors Facilitates the Release of Growth Hormone-Releasing Hormone from Rat Hypothalamus in vitroJournal of Neuroendocrinology, 1989
- Electron-Microscopic Immunocytochemistry of Neuropeptide Y Immunoreactive Innervation of Vasopressin Neurons in the Paraventricular Nucleus of the Rat HypothalamusCells Tissues Organs, 1989
- Neuropeptide Y injected into the supraoptic nucleus causes secretion of vasopressin in the unanesthetized ratNeuroscience Letters, 1987
- Release of Somatostatin-like Immunoreactivity from Incubated Rat Hypothalamus and Cerebral CortexJCI Insight, 1982